Serum interleukin-1β in neonatal sepsis

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 3, 1996, Pages 371-374

  Atici, A ^a,b   Satar, M ^a   Alparslan, N ^b  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Interleukin 1 beta; Neonatal; Sepsis

Indexed keywords

INTERLEUKIN 1BETA;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SEPSIS; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0029670129     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14036.x     Document Type: Article

References (16)

1. Dinarello CA. The proinflamatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 1991;163:1177-84
2. Sullivan JS, Kilpatrick L, Costarino AT, Lee SC, Harris MC. Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediatr 1992;120:510-5
3. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-52
4. Dinarello CA, Mier JW. Lymphokines. N Engl J Med 1987;317:940-5
5. Miller LC, Isa S, LoPreste G, Schaller JG, Dinarello CA. Neonatal interluekin-1β interleukin-6, and tumor necrosis factor: cord blood levels and cellular production. J Pediatr 1990;117: 961-5
6. de Bont ESJM, Martens A, van Raan J, Samson G, Fetter WPF, Okken A, et al. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 plasma levels in neonatal sepsis. Pediatr Res 1993;33:380-3
7. Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JWM, et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990;161:79-84
8. Girardin E, Grau GE, Dayer JM, Roux-Lombard P, The J5 Study Group, Lambert PH. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 1988;319:397-400
9. Özdemir A, Oygür N, Gültekin M, Coşkun M, Yeg̃in O. Neonatal tumor necrosis factor, interleukin-α, interleukin-β and interleukin-6 response to infection. Am J Perinatol 1994;11:282-5
10. Memişoǧlu H, Aksu HSZ, Erken E, Göçük M. Serum IL-1 levels in Behçet's disease. In: O'Duffy JD and Kökmen E, editors. Behçet's disease: basic and clinical aspects. New York: Marcel Decker, 1991
11. Luger A, Graf H, Schwarz HP, Stummvoll HK, Luger TA. Decreased serum interleukin-1 activity and monocyte IL-1 production in patients with fatal sepsis. Crit Care Med 1986;14: 458-61
12. Knudsen PJ, Dinarello CA, Storm TB. Prostaglandins post-transcriptionally inhibit monocyte expression of interleukin-1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol 1986;137:3189-94
13. Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA. Potential antiinflamatory effects of interleukin-4: suppression of human monocyte tumor necrosis factor, interleukin-1 and prostaglandin E2. Proc Natl Acad Sci USA 1989;86:3803-7
14. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1 and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990;76:40-7
15. Matsuzaki N, Saji F, Kameda T. In vitro and in vivo production of interleukin-6 by fetal mononuclear cells. Clin Immunol Immunopathol 1990;55:305-14
16. Groll AH, Meiser A, Weise M. Interleukin-6 as early mediator in neonatal sepsis. Pediatr Infect Dis 1992;11:496